Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
05/2007
05/16/2007CN1315850C Axial substituted phthalocyanine compound, its preparation and application in optical kinetic treatment
05/15/2007US7217736 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
05/15/2007US7217457 Mixture of hydrophobic polymer core and nanoparticles; immobilization
05/10/2007WO2005094884A3 Boron containing nanoparticles targeted to t-cells
05/09/2007EP1781339A1 Compounds of the inventions of guanylyl cyclase c
05/09/2007EP1781336A2 Novel hydrogels and uses thereof
05/09/2007EP1781329A1 Therapy device and related accessories, compositions, and treatment methods
05/09/2007EP1781170A1 Adduct of fluorescent dye and tumor avid tetrapyrrole
05/08/2007US7214377 Method to prepare compositions comprising yeast treated with electromagnetic energy
05/08/2007US7214223 Photoatherolytic catheter apparatus and method
05/03/2007WO2007048635A1 Method of activating a photosensitizer
05/03/2007US20070099887 Photodynamic therapy for the treatment of prostatic conditions
05/03/2007US20070099878 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases
05/03/2007US20070098732 Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer
05/03/2007DE19940220B4 Medizinisches Präparat zur Behandlung von Arthrose, Arthritis und anderen rheumatischen Gelenkerkrankungen A medical preparation for the treatment of osteoarthritis, arthritis and other rheumatic joint diseases
05/02/2007EP1779891A1 Method of activating a photosensitizer
05/02/2007EP1778294A2 Erythrosin-based antimicrobial photodynamic therapy compound and its use
05/02/2007EP1778082A1 Carboranylporphyrins and uses thereof
05/02/2007EP1470127B1 N, n'-dimethylated n-confused porphyrins
05/01/2007US7211562 cytotoxic agents followed by a heat shock protein 90 inhibitor, has a synergistic effect on the growth inhibition of cells; destroying cells having a cell proliferative disorder with wild-type retinoblastoma gene
05/01/2007US7211394 Providingformulation comprising a nascent protein comprising an affinity marker and a photocleavable detectable label, and ) a surface comprising an acceptor molecule; and interacting affinity marker with acceptor molecule so as to form a protein coated surface
04/2007
04/26/2007US20070092549 Delivering magnetic antimitotic agent in manner more toxic to cancer than normal cells while maintaining high concentration for a sustained period of time
04/26/2007US20070092447 Contrast agent for combined modality imaging and methods and systems thereof
04/25/2007EP1776952A2 Photodecontamination of pathogens in blood
04/24/2007US7208159 For orally administering yeast cells cultured in presence of alternating electric field having a frequency in the range of 9500-13500 MHz and a field strength in the range of 200-450 mV/cm
04/24/2007US7208158 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active
04/24/2007CA2242768C Activatable infusable dispersions and methods for using them for therapy and diagnostics
04/19/2007WO2007042833A2 Arnphiphilic nanotubes and micelles comprising same for use in the delivery of biologically active agents
04/19/2007WO2007042775A2 Conjugates of photosensitisers and antibodies
04/19/2007WO2007019845A3 Method for encapsulating therapeutic substances in cells
04/19/2007WO2004099375A3 Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use therof
04/19/2007US20070087046 Use of green porphyrins to treat neovasculature in the eye
04/19/2007US20070086982 Gene therapy for regulating smooth muscle tone
04/19/2007US20070086973 Drug delivery systems for photodynamic therapy
04/19/2007US20070084474 Dosimetry for californium-252 (252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereof
04/19/2007CA2624841A1 Conjugates of photosensitisers and antibodies
04/18/2007EP1774989A2 Treatment of cancer with high intensity focused ultrasound and chemotherapy
04/18/2007EP1773988A2 Methods for inducing the differentiation of blood monocytes into functional dendritic cells
04/18/2007EP1773404A2 Methylamine risks and treatment with n-derivatives of hyperactivity, depression and alcoholism
04/18/2007EP1773360A2 Acute inflammatory condition treatment
04/18/2007EP1556061B1 Photokinetic delivery of biologically active substances using pulsed incoherent light
04/18/2007EP1401479B1 Detection and therapy of vulnerable plaque with photodynamic compounds
04/18/2007EP1135160B1 Boron neutron capture therapy using pre-targeting methods
04/18/2007CN1950111A Activatable particles, preparations and uses.
04/18/2007CN1950109A Compositions comprising cells and magnetic materials for targeted delivery
04/18/2007CN1310652C Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
04/17/2007US7204988 Method to prepare compositions comprising yeast treated with electromagnetic energy
04/17/2007US7204987 Biological compositions and methods for treatment of prostate cancer
04/17/2007US7204986 Comprising live yeast cells produced by culturing yeast cells in the presence of a series of electromagnetic fields such that the yeast cells become metabolically active
04/12/2007WO2007039646A1 Transdermal delivery system for treating infertility
04/12/2007US20070081946 Assembly of gas-filled microvesicle with active component for contrast imaging
04/11/2007EP1567163B1 Method of treating nausea, vomiting, retching or any combination thereof
04/10/2007US7201906 Method to prepare compositions comprising yeast treated with electromagnetic energy
04/10/2007US7201892 using carbocyanine dyes; photodynamic therapy; supplying to tumors
04/10/2007US7201765 Method and apparatus for acne treatment
04/10/2007CA2389896C Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation
04/10/2007CA2200061C Container with multi-phase composition for use in diagnostic and therapeutic applications
04/05/2007WO2007036682A1 Coated microspheres
04/05/2007US20070078501 Phototreatment device for use with coolants and topical substances
04/05/2007US20070078108 Liquid composition for bulging mucous membrane for use in endoscopic surgery comprising a chitosan derivative containing carbohydrate chains
04/05/2007US20070078076 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
04/03/2007US7199162 Pretreatment before allogenic transplantation of bone marrow or haematopoietic stem cells; may be administered with other chemotherapeutic or immunosuppressive agents; antitumor and anticarcinogenic agents
04/03/2007US7198949 Compositions and methods for altering the biodistribution of biological agents
04/03/2007US7198783 Sensitization of neoplastic cells to radiation therapy with reovirus
04/03/2007US7198778 Cyanine dye bioconjugates useful for diagnostic imaging and therapy
04/03/2007US7198634 Phototherapeutic treatment of skin conditions
04/03/2007CA2210152C Green porphyrins as immunomodulators
03/2007
03/29/2007WO2007004045A3 Use of a photosensitizing agent in the treatment or prevention of an inflammation-associated disorder in the gastrointestinal tract of a mammal
03/29/2007US20070073197 Assessment and control of acoustic tissue effects
03/29/2007US20070071685 Gas-filled microvesicle assembly for contrast imaging
03/28/2007EP1767215A1 Isoflavones against radiation-induced mortality
03/28/2007EP1292298B1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
03/27/2007US7195874 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures
03/22/2007US20070067006 Phototreatment device for use with coolants
03/22/2007US20070066513 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization
03/20/2007CA2142280C Metal-mediated cross-coupling with ring-metalated porphyrins
03/15/2007WO2007028984A1 Apparatus and method for sonoporation
03/15/2007WO2007028981A1 Apparatus and method for sonoporation
03/15/2007WO2006091666A3 Methods and compositions for treating conditions of the eye
03/15/2007US20070060906 Method, reagent, and device for embolizing blood vessels in tumors with ultrasonic radiation micro-bubble reagent
03/15/2007US20070059316 Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted pdt agents
03/15/2007US20070059248 Oxygen delivery agents and uses for the same
03/14/2007EP1467706B1 Dermal application system for aminolevulinic acid-derivatives
03/14/2007CN1929849A Liquid composition for bulging mucous membrane for use in endoscopic surgery comprising a chitosan derivative containing carbohydrate chains
03/13/2007CA2273010C Use of green porphyrins for the manufacture of a medicament for the treatment of secondary cataracts
03/08/2007WO2007026725A2 Drug, drug gudance system, magnetic detection system, and drug design method
03/08/2007US20070053931 Dietary supplements for treating hypertension
03/07/2007EP1406591B1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone
03/07/2007CN1925877A Methylamine risks and treatment with N-derivatives of hyperactivity, depression and alcoholism
03/07/2007CN1303090C Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
03/07/2007CN1302815C Toluidine blue O drug substance and use thereof for in VIVO Staining and chemo therapeutic treatment of dysplastic tissues
03/07/2007CN1302777C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
03/06/2007US7186246 Ultrasound catheter with utility lumen
03/01/2007WO2006105507A3 Indoloquinone tumor radiation sensitization
03/01/2007US20070049514 Resonance modulator for diagnosis and therapy
02/2007
02/28/2007EP1755733A2 Methods and devices for thermal treatment
02/28/2007EP1755676A1 Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins
02/28/2007EP1755584A1 Treatment of myopia
02/28/2007EP1392666B1 Biologically active methylene blue derivatives
02/27/2007US7183378 Bringing about refolding of protein wherein solution or suspension of protein is subjected to low intensity sound waves at frequency above 10 kHz and below 1 MHz, at low enough intensity that protein is not denatured, intensity being less than that at which sonocavitation occurs
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 95